![Charles Baum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Baum
Directeur/Bestuurslid bij
PMV PHARMACEUTICALS, INC.
Vermogen: 14 986 $ op 31-05-2026
Profiel
Dr. Charles M. Baum is Voorzitter bij Oncomyx Therapeutics, Inc. en President, Chief Executive Officer & Director bij Mirati Therapeutics, Inc. Hij zetelt in de Raad van Bestuur van PMV Pharmaceuticals, Inc., BCTG Acquisition Corp. en Mirati Therapeutics, Inc. Dr. Baum was voorheen werkzaam als Onafhankelijk Bestuurder bij Immunomedics, Inc., als Onafhankelijk Bestuurder bij Array BioPharma, Inc. en als Senior VP-Biotherapeutisch Klinisch Onderzoek bij Pfizer Inc. Hij behaalde zijn doctoraat aan de Washington University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-05-2026 | 9.366 ( 0,02% ) | 14 986 $ | 31-05-2026 | |
| 04-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Charles Baum
| Bedrijven | Functie | Begin |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-04-2021 |
| ACRIVON THERAPEUTICS, INC. | Directeur/Bestuurslid | 22-06-2023 |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Voorzitter | 06-11-2020 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Algemeen Directeur | 25-07-2024 |
Crossbow Therapeutics, Inc.
 Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Directeur/Bestuurslid | - |
Eerdere bekende functies van Charles Baum
| Bedrijven | Functie | Einde |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Directeur/Bestuurslid | 08-01-2025 |
| MIRATI THERAPEUTICS | Algemeen Directeur | 23-01-2024 |
| TANGO THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2021 |
| IMMUNOMEDICS, INC. | Directeur/Bestuurslid | 23-10-2020 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Charles Baum
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
82
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Technology Services |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Health Technology |
